Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edit functionality is currently unavailable.

William Thomas Clarke, M.D.


Beth Israel Deaconess Medical Center, Boston, MA06/2019Gastroenterology
University of California, San Francisco, San Francisco, CA06/2016Internal Medicine
Yale School of Medicine, New Haven, CTMD05/2013
University of Oxford, Oxford, UKMSc05/2009Physiology, Anatomy and Genetics
University of California, Los Angeles, Los Angeles, CABS03/2007Molecular Cell and Developmental Biology

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Papamichael K, Thomas VJ, Banty A, Clarke WT, Germansky KA, Flier SN, Feuerstein JD, Melmed GY, Cheifetz AS. Clinical Impact of Corrections to Infliximab and Adalimumab Monitoring Results with the Homogeneous Mobility Shift Assay. J Clin Med. 2020 Sep 02; 9(9). PMID: 32887317.
  2. Papamichail K, Clarke WT, Casteele NV, Germansky KA, Feuerstein JD, Melmed GY, Siegel CA, Irving PM, Cheifetz AS. Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2020 Mar 05. PMID: 32147594.
  3. Clarke WT, Papamichael K, Vande Casteele N, Germansky KA, Feuerstein JD, Melmed GY, Siegel CA, Irving PM, Cheifetz AS. Infliximab and Adalimumab Concentrations May Vary Between the Enzyme-Linked Immunosorbent Assay and the Homogeneous Mobility Shift Assay in Patients With Inflammatory Bowel Disease: A Prospective Cross-Sectional Observational Study. Inflamm Bowel Dis. 2019 10 18; 25(11):e143-e145. PMID: 31559417.
  4. Clarke WT, Feuerstein JD. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments. World J Gastroenterol. 2019 Aug 14; 25(30):4148-4157. PMID: 31435169.
  5. Clarke WT, Feuerstein JD. Editorial: older patients are significantly more likely to have colon ischaemia-associated conditions that are chronic and complex. Aliment Pharmacol Ther. 2019 08; 50(3):329-330. PMID: 31313367.
  6. Clarke WT, Miranda J, Neidich E, Hudock R, Peters MG, Kelly EM. Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B. J Viral Hepat. 2019 10; 26(10):1164-1169. PMID: 31134715.
  7. Clarke WT, Feuerstein JD. After surgery for stage II or III colorectal cancer, more vs less frequent follow-up did not differ for 5-year mortality. Ann Intern Med. 2018 10 16; 169(8):JC38. PMID: 30326082.
    Citations:    Fields:    
  8. Clarke WT, Feuerstein JD. Updates in colorectal cancer screening in inflammatory bowel disease. Curr Opin Gastroenterol. 2018 07; 34(4):208-216. PMID: 29771698.
    Citations:    Fields:    
  9. Clarke WT, Amin SS, Papamichael K, Feuerstein JD, Cheifetz AS. Patients with core antibody positive and surface antigen negative Hepatitis B (anti-HBc+, HBsAg-) on anti-TNF therapy have a low rate of reactivation. Clin Immunol. 2018 06; 191:59-62. PMID: 29601854.
    Citations:    Fields:    
  10. Clarke WT, Marks PW. Gemtuzumab ozogamicin: is there room for salvage? Blood. 2010 Oct 07; 116(14):2618-9. PMID: 20930085.
    Citations: 3     Fields:    Translation:Humans
  11. Clarke WT, Edwards B, McCullagh KJ, Kemp MW, Moorwood C, Sherman DL, Burgess M, Davies KE. Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. J Cell Sci. 2010 Aug 01; 123(Pt 15):2543-52. PMID: 20587592.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  12. Kemp MW, Edwards B, Burgess M, Clarke WT, Nicholson G, Parry DA, Davies KE. Syncoilin isoform organization and differential expression in murine striated muscle. J Struct Biol. 2009 Mar; 165(3):196-203. PMID: 19070665.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  13. Bekker JM, Colantonio JR, Stephens AD, Clarke WT, King SJ, Hill KL, Crosbie RH. Direct interaction of Gas11 with microtubules: implications for the dynein regulatory complex. Cell Motil Cytoskeleton. 2007 Jun; 64(6):461-73. PMID: 17366626.
    Citations: 13     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Clarke's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (90)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.